Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: Pathogenetic and clinical implications

Andrea D'Osualdo, Francesca Ferlito, Ignazia Prigione, Laura Obici, Antonella Meini, Francesco Zulian, Alessandra Pontillo, Fabrizia Corona, Roberto Barcellona, Marco Di Duca, Giuseppe Santamaria, Francesco Traverso, Paolo Picco, Maurizia Baldi, Alessandro Plebani, Roberto Ravazzolo, Isabella Ceccherini, Alberto Martini, Marco Gattorno

Research output: Contribution to journalArticle

Abstract

Objective. To explore tumor necrosis factor (TNF)-induced apoptosis in neutrophils from patients with TNF receptor-associated periodic syndrome (TRAPS) and to correlate the results with the different kinds of TNFRSF1A mutations. Methods. Two hundred sixty-five patients with clinically suspected inherited autoinflammatory syndrome were screened for mutations of the TNFRSF1A gene. Neutrophils were isolated from heparinized blood by dextran sedimentation and incubated with and without cycloheximide (CHX) and TNFα. Cell apoptosis was assessed by human annexin V binding, and caspase 8 activation was assessed by flow cytometry. Results. Twenty-one patients were found to carry a variant of the TNFRSF1A gene: 13 patients had an R92Q substitution, and 8 patients presented other missense substitutions, 1 splicing mutation, and 1 in-frame interstitial deletion. Neutrophil stimulation with TNF and CHX was associated with induction of apoptosis in 12 normal controls and in 10 subjects with the R92Q mutation. Conversely, neutrophils from 8 TRAPS patients with mutations of cysteine or threonine residues or interstitial deletion did not show any induction of apoptosis after stimulation. The incidence of the R92Q mutation among patients with recurrent autoinflammatory syndromes was similar to that observed in the normal population. Conclusion. Resistance to TNF-mediated apoptosis is a feature in TRAPS patients who have mutations of cysteine residues or interstitial deletion, and may play a pathogenic role. The R92Q mutation does not appear to be significantly associated with TRAPS.

Original languageEnglish
Pages (from-to)998-1008
Number of pages11
JournalArthritis and Rheumatism
Volume54
Issue number3
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Neutrophils
Tumor Necrosis Factor-alpha
Apoptosis
Mutation
Cycloheximide
Cysteine
Caspase 8
Annexin A5
Blood Sedimentation
Threonine
Dextrans
Genes
Flow Cytometry
Autosomal Dominant Familial Periodic Fever
Incidence
Population

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis : Pathogenetic and clinical implications. / D'Osualdo, Andrea; Ferlito, Francesca; Prigione, Ignazia; Obici, Laura; Meini, Antonella; Zulian, Francesco; Pontillo, Alessandra; Corona, Fabrizia; Barcellona, Roberto; Di Duca, Marco; Santamaria, Giuseppe; Traverso, Francesco; Picco, Paolo; Baldi, Maurizia; Plebani, Alessandro; Ravazzolo, Roberto; Ceccherini, Isabella; Martini, Alberto; Gattorno, Marco.

In: Arthritis and Rheumatism, Vol. 54, No. 3, 03.2006, p. 998-1008.

Research output: Contribution to journalArticle

D'Osualdo, Andrea ; Ferlito, Francesca ; Prigione, Ignazia ; Obici, Laura ; Meini, Antonella ; Zulian, Francesco ; Pontillo, Alessandra ; Corona, Fabrizia ; Barcellona, Roberto ; Di Duca, Marco ; Santamaria, Giuseppe ; Traverso, Francesco ; Picco, Paolo ; Baldi, Maurizia ; Plebani, Alessandro ; Ravazzolo, Roberto ; Ceccherini, Isabella ; Martini, Alberto ; Gattorno, Marco. / Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis : Pathogenetic and clinical implications. In: Arthritis and Rheumatism. 2006 ; Vol. 54, No. 3. pp. 998-1008.
@article{5bb4a18912a74069ad19aa15ab83852d,
title = "Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: Pathogenetic and clinical implications",
abstract = "Objective. To explore tumor necrosis factor (TNF)-induced apoptosis in neutrophils from patients with TNF receptor-associated periodic syndrome (TRAPS) and to correlate the results with the different kinds of TNFRSF1A mutations. Methods. Two hundred sixty-five patients with clinically suspected inherited autoinflammatory syndrome were screened for mutations of the TNFRSF1A gene. Neutrophils were isolated from heparinized blood by dextran sedimentation and incubated with and without cycloheximide (CHX) and TNFα. Cell apoptosis was assessed by human annexin V binding, and caspase 8 activation was assessed by flow cytometry. Results. Twenty-one patients were found to carry a variant of the TNFRSF1A gene: 13 patients had an R92Q substitution, and 8 patients presented other missense substitutions, 1 splicing mutation, and 1 in-frame interstitial deletion. Neutrophil stimulation with TNF and CHX was associated with induction of apoptosis in 12 normal controls and in 10 subjects with the R92Q mutation. Conversely, neutrophils from 8 TRAPS patients with mutations of cysteine or threonine residues or interstitial deletion did not show any induction of apoptosis after stimulation. The incidence of the R92Q mutation among patients with recurrent autoinflammatory syndromes was similar to that observed in the normal population. Conclusion. Resistance to TNF-mediated apoptosis is a feature in TRAPS patients who have mutations of cysteine residues or interstitial deletion, and may play a pathogenic role. The R92Q mutation does not appear to be significantly associated with TRAPS.",
author = "Andrea D'Osualdo and Francesca Ferlito and Ignazia Prigione and Laura Obici and Antonella Meini and Francesco Zulian and Alessandra Pontillo and Fabrizia Corona and Roberto Barcellona and {Di Duca}, Marco and Giuseppe Santamaria and Francesco Traverso and Paolo Picco and Maurizia Baldi and Alessandro Plebani and Roberto Ravazzolo and Isabella Ceccherini and Alberto Martini and Marco Gattorno",
year = "2006",
month = "3",
doi = "10.1002/art.21657",
language = "English",
volume = "54",
pages = "998--1008",
journal = "Arthritis care and research : the official journal of the Arthritis Health Professions Association",
issn = "0893-7524",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis

T2 - Pathogenetic and clinical implications

AU - D'Osualdo, Andrea

AU - Ferlito, Francesca

AU - Prigione, Ignazia

AU - Obici, Laura

AU - Meini, Antonella

AU - Zulian, Francesco

AU - Pontillo, Alessandra

AU - Corona, Fabrizia

AU - Barcellona, Roberto

AU - Di Duca, Marco

AU - Santamaria, Giuseppe

AU - Traverso, Francesco

AU - Picco, Paolo

AU - Baldi, Maurizia

AU - Plebani, Alessandro

AU - Ravazzolo, Roberto

AU - Ceccherini, Isabella

AU - Martini, Alberto

AU - Gattorno, Marco

PY - 2006/3

Y1 - 2006/3

N2 - Objective. To explore tumor necrosis factor (TNF)-induced apoptosis in neutrophils from patients with TNF receptor-associated periodic syndrome (TRAPS) and to correlate the results with the different kinds of TNFRSF1A mutations. Methods. Two hundred sixty-five patients with clinically suspected inherited autoinflammatory syndrome were screened for mutations of the TNFRSF1A gene. Neutrophils were isolated from heparinized blood by dextran sedimentation and incubated with and without cycloheximide (CHX) and TNFα. Cell apoptosis was assessed by human annexin V binding, and caspase 8 activation was assessed by flow cytometry. Results. Twenty-one patients were found to carry a variant of the TNFRSF1A gene: 13 patients had an R92Q substitution, and 8 patients presented other missense substitutions, 1 splicing mutation, and 1 in-frame interstitial deletion. Neutrophil stimulation with TNF and CHX was associated with induction of apoptosis in 12 normal controls and in 10 subjects with the R92Q mutation. Conversely, neutrophils from 8 TRAPS patients with mutations of cysteine or threonine residues or interstitial deletion did not show any induction of apoptosis after stimulation. The incidence of the R92Q mutation among patients with recurrent autoinflammatory syndromes was similar to that observed in the normal population. Conclusion. Resistance to TNF-mediated apoptosis is a feature in TRAPS patients who have mutations of cysteine residues or interstitial deletion, and may play a pathogenic role. The R92Q mutation does not appear to be significantly associated with TRAPS.

AB - Objective. To explore tumor necrosis factor (TNF)-induced apoptosis in neutrophils from patients with TNF receptor-associated periodic syndrome (TRAPS) and to correlate the results with the different kinds of TNFRSF1A mutations. Methods. Two hundred sixty-five patients with clinically suspected inherited autoinflammatory syndrome were screened for mutations of the TNFRSF1A gene. Neutrophils were isolated from heparinized blood by dextran sedimentation and incubated with and without cycloheximide (CHX) and TNFα. Cell apoptosis was assessed by human annexin V binding, and caspase 8 activation was assessed by flow cytometry. Results. Twenty-one patients were found to carry a variant of the TNFRSF1A gene: 13 patients had an R92Q substitution, and 8 patients presented other missense substitutions, 1 splicing mutation, and 1 in-frame interstitial deletion. Neutrophil stimulation with TNF and CHX was associated with induction of apoptosis in 12 normal controls and in 10 subjects with the R92Q mutation. Conversely, neutrophils from 8 TRAPS patients with mutations of cysteine or threonine residues or interstitial deletion did not show any induction of apoptosis after stimulation. The incidence of the R92Q mutation among patients with recurrent autoinflammatory syndromes was similar to that observed in the normal population. Conclusion. Resistance to TNF-mediated apoptosis is a feature in TRAPS patients who have mutations of cysteine residues or interstitial deletion, and may play a pathogenic role. The R92Q mutation does not appear to be significantly associated with TRAPS.

UR - http://www.scopus.com/inward/record.url?scp=33644878847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644878847&partnerID=8YFLogxK

U2 - 10.1002/art.21657

DO - 10.1002/art.21657

M3 - Article

C2 - 16508982

AN - SCOPUS:33644878847

VL - 54

SP - 998

EP - 1008

JO - Arthritis care and research : the official journal of the Arthritis Health Professions Association

JF - Arthritis care and research : the official journal of the Arthritis Health Professions Association

SN - 0893-7524

IS - 3

ER -